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Endovascular treatment for type B aortic dissection in a patient 
with Loeys-Dietz syndrome accompanied by potential lung cancer
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　Loeys-Dietz syndrome is a recently recognized genetic connective tissue disorder. Aortic 
involvement in Loeys-Dietz syndrome is known to be more aggressive, even in young patients. Earlier 
and wider ranging surgical treatment is recommended because of the aggressive nature of its aortic 
pathology. We report the case of a 17-year-old girl diagnosed with acute type B aortic dissection 
accompanied by potential lung cancer. Because of rapid enlargement of the dissected aorta, urgent 
surgical intervention was considered to be mandatory. Considering the possible malignancy of the 
lung tumor, we reluctantly performed palliative thoracic endovascular aortic repair as an alternative 
to open surgery. However, endovascular treatment resulted in further expansion of the dissected 
aorta. Additional stent graft deployment at downstream aorta was performed and the false lumen 
flow was decreased significantly. Postoperative computed tomographic examination showed decreased 
descending aortic diameter with progressive false lumen thrombosis. In patients with Loeys-Dietz 
syndrome, the application of endovascular therapy should be performed more carefully than expected, 
especially if there is a reason that open surgery would be unsuitable. 
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Introduction
Loeys-Dietz syndrome（LDS）is a recently 
recognized multisystem connective tissue disorder
（CTD）character ized by cran io fac ia l  and 
musculoskeletal abnormalities and aggressive aortic 
pathologies.１），２）This genetic disorder has similarities 
with Marfan syndrome（MFS）; however, the aortic 
disease in LDS is known to be more aggressive, even 
in younger patients. Because of the aggressive nature 
of aortic pathologies, earlier and wider surgical 
intervention is recommended, whereas the application 
of endovascular treatment is still controversial 
in pat ients with LDS,  as in other CTDs.３） 
In this article, we report our surgical experience in 
the case of a 17-year-old girl with LDS who possibly 
had lung cancer. She exhibited acute type B aortic 
dissection presenting extreme rapid enlargement of 
the dissected aorta and required urgent repeated 
thoracic endovascular aortic repair（TEVAR）. 
Written informed consent was obtained from her 
parents for publication of this report.
Case report
A 17-year-old girl visited the emergency room
（ER）of our hospital with a complaint of sudden-
onset, severe back pain. The patient’s family history 
was unremarkable. She had undergone repeated 
open aortic surgeries at our institution. At 7 years of 
age, she had undergone a Bentall operation using a 
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stentless aortic root bioprosthesis for an annuloaortic 
ectasia and significant aortic regurgitation. At 
that time, physical examination demonstrated 
hypertelorism and bifid uvula, which suggested LDS. 
The diagnosis of LDS was confirmed by the detection 
of a mutation in the transforming growth factor-beta 
receptor type 1（TGF-βR1）gene at the age of 10. 
During the follow-up, gradual enlargement of the 
aortic arch, to over 70 mm, was observed through 
annual computed tomography（CT）imaging. When 
she was 14 years old, graft replacement of the aortic 
arch and reconstruction of the brachicephalic artery 
and the left common carotid artery was performed.
On arrival at ER, her blood pressure was stable 
and laboratory examination showed no abnormal 
findings, although she complained of mild back pain. 
A CT revealed type B aortic dissection, from the 
descending aorta to the level of the diaphragm. 
The false lumen was patent and the maximum 
diameter of the descending aorta was 20 mm
（Fig. 1a, d）. Despite the strict antihypertensive 
treatment, follow-up CT revealed rapid dilatation of 
the dissected descending aorta from 20 mm to 36 
mm over less than 3 weeks（Fig. 1b）. Furthermore, 
multiple pulmonary nodules were detected; the 
respiratory physician strongly suspected lung cancer
（adenocarcinoma）（Fig. 1c）. Although urgent 
surgical treatment should be mandatory to prevent 
aortic rupture, the application of open surgery 
requiring cardiopulmonary bypass was considered to 
be controversial because of its immunosuppressive 
effect on potential lung cancer. On the other hand, 
the use of TEVAR for the connective tissue disorder 
is more controversial. Considering the aortic 
emergency and the possible malignancy of the lung 
tumor, we decided to perform palliative TEVAR as 
an alternative to open surgery.
Under general anesthesia, the operation was 
performed. Intraoperative angiography was 
performed via right transbrachial route. The stent 
graft（The Bolton Relay Thoracic Stent Graft: 
Bolton Medical, Sunrise, FL, USA）was deployed at 
the proximal descending aorta to cover the primary 
entry tear. The surgical graft of the previous aortic 
arch repair was used as a proximal landing zone 
for endograft fixation. Then, the bare metal stent 
component（The Zenith Dissection Endovascular 
System: Cook Medical, Bloomington, IN, USA）
was deployed to the narrow true lumen of the 
downstream aorta. Intraoperative angiography 
showed decreased false lumen blood flow, except for 
minimal flow through a pre-existing reentry point at 
the abdominal aorta.





Figure 1． Preoperative computed tomography image: a, Soon after the onset of type B acute aortic 
dissection. The false lumen was patent and maximum diameter of the dissected descending aorta was 20 
mm （white arrow）; b, Three weeks after the onset. The dissected descending aorta was enlarged to 36 
mm （white arrow）, the true lumen was very narrow; c, Multiple pulmonary nodules were demonstrated 
（green circles）; d, Reconstructed three-dimensional image of the entire aorta at the time of onset. Type B 
aortic dissection, from the descending aorta to the level of the diaphragm was seen.
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follow-up CT at 2 weeks after primary TEVAR 
demonstrated an increasing descending aortic 
diameter from 36 mm to 48 mm（Fig. 2a, b）. The 
descending aorta was enlarged with persistent 
false lumen blood flow（Fig. 2c）. Furthermore, 
the dissection of brachiocephalic artery was seen. 
Since the aortic dissection continued to progress in 
spite of entry closure with primary TEVAR and 
antihypertensive therapy, secondary TEVAR was 
planned to reduce persistent false lumen blood flow. 
Angiography demonstrated increased false lumen 
flow through the new intimal tear induced by the 
distal end of the stent graft. Additional stent graft 
deployment was performed and the false lumen 
flow was decreased significantly. The postoperative 
course was uneventful, and she was discharged on 
postoperative day 12. After a 14-month follow-up 
period, she continues to do well. Although recent CT 
image showed decreased descending aortic diameter
（41 mm）with progressive false lumen thrombosis
（Fig. 3a, b, c）, her untreated native aorta remains 
at high risk for adverse events. The diameter of 
a b c
Figure 2． Computed tomography after primary TEVAR: a, Soon after primary TEVAR. The descending 
aorta treated with TEVAR was enlarged to a diameter of 36 mm. The dotted lines showed actual aortic 
outlines; b, Two weeks after primary TEVAR. The descending aortic diameter was increased to 48 
mm. The brachiocephalic artery showed dissection (black arrowhead). Its diameter was 21 mm; c, The 
descending aorta was enlarged, with persistent false lumen blood flow. The maximum diameter was 48 mm.
TEVAR, thoracic endovascular aortic repair.
a b
c
Figure 3． Follow-up computed tomography (14 months after TEVAR): a, Reconstructed three-dimensional 
image of the entire aorta. The descending aortic diameter was decreased. Dotted lines showed actual 
aortic outlines. The dissected brachiocephalic artery was slightly enlarged; b, The false lumen showed 
remarkable shrinkage; c, The false lumen was still patent but the thrombosis had progressed markedly. 
The diameter of the descending aorta had decreased to 41 mm.
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the dissected brachiocephalic artery was slightly 
increased to 22 mm. On the other hand, the size and 
number of pulmonary nodules were also unchanged. 
Timely recognition of progressive aortic disease and 
appropriate timing of aortic re-intervention are major 
concerns for proper management in the near future.
Discussion
LDS is a rare genetic CTD first described in 
2005.1）Although LDS has similarities with MFS, 
they have distinctive phenotypes and genetic 
features. LDS is an autosomal dominant genetic 
disorder caused by the mutation of the TGF-βR1 or 
2 genes, whereas MFS is caused by the mutation of 
the gene coding for fibrillin-1. LDS is phenotypically 
characterized by the triad of hypertelorism, bifid 
uvula, and/or cleft palate as well as generalized 
arterial tortuosity throughout the entire aortic 
system.２）These characteristics are not found 
in patients with MFS. The differential diagnosis 
between the two syndromes is important because 
the progression and prognosis of aortic and branch 
vessel disease in both conditions is significantly 
different.２），４）Compared with MFS, the vascular 
pathology in LDS tends to be more aggressive, even 
in younger patients. Because of a higher incidence 
of aortic adverse events, an earlier and wider 
surgical strategy is occasionally needed to prolong 
the patient’s life expectancy. In LDS patients with 
acute aortic dissection, rapid aortic enlargement was 
seen to occur within a short period even if optimal 
hypertensive therapy was administered.５），６）
Inoue et al. reported a 6-year-old boy diagnosed 
with acute type B dissection whose dissected aorta 
enlarged from 36 mm to 39 mm within 2 weeks.５）
In our present case, the disease progression was 
more rapid than that seen in previous reported LDS 
cases.５），６）The dissected descending aorta dilated 
from 20 mm to 36 mm in less than 3 weeks after 
the onset. Furthermore, it was very surprising that 
follow-up CT at 2 weeks after primary TEVAR 
revealed an increasing descending aortic diameter 
from 36 mm to 48 mm. In addition to the fragility of 
the aortic wall, which is normally seen in patients 
with LDS, the radial force of the endovascular graft 
was strong enough not only to dilate the true lumen 
but also to enhance the total aortic enlargement. 
Furthermore, the new dissection of brachiocephalic 
artery appeared after primary TEVAR. Once acute 
aortic dissection appears in patients with LDS, rapid 
progression of aortic pathology is a major concern 
during acute patient management. LDS patients with 
acute aortic dissection require frequent follow-up CT 
examination during hospitalization, because a lack of 
follow-up monitoring may also lead to a catastrophic 
aortic event.
Although improvements in patient care have 
prolonged survival of patients with CTDs, their 
entire native aorta remains at high risk.３）Graft 
replacement of diseased aorta with open surgery 
is considered to be the gold standard in treatment. 
Even in the evolving endovascular era, the use of 
TEVAR for CTDs is still controversial.３）Roselli et 
al. reported their surgical experience of 121 patients 
with CTDs.３）Of these, only 2 patients underwent 
primary TEVAR for acute complicated type B 
dissection, except for hybrid or staged TEVAR 
cases. They mentioned that both patients were 
deemed high risk for emergent open repair. In 
elective hybrid or staged TEVAR, the surgical grafts 
from previous repairs provided a stable landing 
zone for endograft fixation. If a good proximal 
landing zone was not available, an open approach 
was preferred. A staged approach with the use of 
a combination of open and endovascular repair is a 
feasible strategy whose benefits outweigh the risks 
in patients with CTDs. With careful patient selection, 
TEVAR may prove to be a valuable tool for aortic 
emergencies even in patients with CTDs.７）However, 
according to previous reports, including the present 
case,５），６）LDS seems to be more aggressive and 
progressive than other CTDs. In our case, palliative 
TEVAR was reluctantly taken into consideration to 
treat the life-threatening rapid progression of aortic 
pathology, because potential lung cancer was highly 
suspected. However, TEVAR in LDS resulted in 
further expansion of the dissected aorta. Therefore, 
in patients with LDS, the application of TEVAR 
should not be considered without careful discusssion, 
especially if there is any reason why the patient 
would be unsuitable for open surgery. Fortunately, in 
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our case, the size and number of pulmonary nodules 
were not dramatically changed during follow-up. 
LDS is known to be associated with hematological 
malignancies, however, there have been no report 
of lung cancer in young patient with LDS. If the 
diagnosis of lung cancer can be ruled out by biopsy, 
open aortic surgery should be considered as an 
alternative to endovascular treatment in the near 
future. In patients with LDS, timely recognition of 
progressive aortic pathology and aggressive surgical 
intervention is crucial for proper management.４），８）
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